Exercise of Warrants and Issue of Equity

RNS Number : 2249E
Braveheart Investment Group plc
04 November 2020
 

4 November 2020

Braveheart Investment Group plc

("Braveheart" or the "Company")

Exercise of Warrants and Issue of Equity

 

Braveheart Investment Group (AIM: BRH) announces that is has received notices of exercise of warrants over 489,772 new ordinary shares of 2p each at a price of 40p per share (the "Warrant Shares") raising a total of £195,908.80. The exercised warrants were granted in conjunction with the placing announced on 1 May 2020.

Application will be made for the  Warrant Shares to be admitted to trading on AIM and it is expected that admission will take place on or around 9 November 2020 ("Admission"). The Warrant Shares will rank pari passu in all respects with the Company's existing ordinary shares.

Total Voting Rights

Upon Admission, the issued share capital of the Company will consist of 35,877,975  ordinary shares of 2p each . The Company does not hold any shares in treasury. Therefore, the total number of voting rights in the Company from Admission will be 35,877,975.  This figure may be used by shareholders as the denominator for the calculations by which they determine if they are required to notify their interest in or a change to their interest in the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

Braveheart Investment Group plc

Tel: 01738 587555

Trevor Brown, Chief Executive Officer

 

 

 

Allenby Capital Limited (Nominated Adviser and Joint Broker)

Tel: 020 3328 5656

David Worlidge / James Hornigold

 

 

 

Peterhouse Capital Limited (Joint Broker)

Tel: 020 7469 0936

Heena Karani / Lucy Williams

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IOEKKQBPFBDKBDK
UK 100

Latest directors dealings